Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ABSTRACT


01 mayo 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Outcome of paravalvular leak repair after transcatheter aortic valve replacement with a balloon‐expandable prosthesis

Abhijeet Dhoble MD, Tarun Chakravarty MD, Mamoo Nakamura MD, Yigal Abramowitz MD, Rikin Tank MD, Hirotsugu Mihara MD, Geeteshwar Mangat MD, Hasan Jilaihawi MD, Takahiro Shiota MD, Raj Makkar MD

Background: Significant paravalvular leak (PVL) occurs in up to 13% of patients after transcatheter aortic valve replacement (TAVR) with a balloon‐expandable bioprosthesis. Transcatheter PVL repair has emerged as a less invasive alternative for this problem.

15 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. TriGuard™ HDH embolic deflection device for cerebral protection during transcatheter aortic valve replacement

Mariam Samim MD, PhD, Bart van der Worp MD, PhD, Pierfrancesco Agostoni MD, PhD, Jeroen Hendrikse MD, PhD, Ricardo P.J. Budde MD, PhD, Freek Nijhoff MD, Faiz Ramjankhan MD, Pieter A. Doevendans MD, PhD, Pieter R. Stella MD, PhD

Objectives: This study aims to evaluate the safety and performance of the new embolic deflection device TriGuard™HDH in patients undergoing TAVR.

15 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. PFO “angioplasty”: The preparation of a very stiff and long tunnel for device closure

Gianfranco Butera MD, PhD, Luciane Piazza MD, Mohamed Heles MD

Introduction: Patent foramen ovale (PFO) closure is a widely performed procedure. Understanding the anatomy is mandatory in order to perform the procedure successfully. The degree of overlap between the septum primum and secundum is called the tunnel. In particular, long and stiff tunnels may prevent the correct positioning of devices that have a fixed distance between the right and left atrial discs.

15 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Percutaneous left atrial appendage occlusion using different technologies in the United Kingdom: A multicenter registry

Timothy R. Betts MD, Milena Leo MD, Sandeep Panikker MD, Prapa Kanagaratnam MD, PhD, Michael Koa‐Wing MD, PhD, David Wyn Davies MD, FHRS, David Hildick‐Smith MD, Dylan G. Wynne PhD, Oliver Ormerod MD, Oliver R. Segal MD, Anthony W. Chow MD, Derick Todd MD, Sandra Cabrera Gomez MD, Graeme J. Kirkwood PhD, David Fox MD, Chris Pepper MD, John Foran MD, Tom Wong MD

Objectives: This study aimed at assessing the feasibility and long‐term efficacy of left atrial appendage occlusion (LAAO) in a “real world” setting.

15 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Invasive angiography and revascularization in patients with stable angina following prior coronary artery bypass grafting: Results from the East Denmark heart registry

Francis R. Joshi, Luigi Biasco, Frants Pedersen, Lene Holmvang, Steffen Helqvist, Hans‐Henrik Tilsted, Ulrik Abildgaard, Henning Kelbaek, Jens F. Lassen, Erik Jørgensen, Ole De Backer, Thomas Engstrøm

Background: There are limited data to guide the optimum approach to patients presenting with angina after coronary artery bypass grafting (CABG). Although often referred for invasive angiography, the effectiveness of this is unknown; angina may also result from diffuse distal or micro‐vascular coronary disease and it is not known how often targets for intervention are identified.

15 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Defining optimal activated clotting time for percutaneous coronary intervention: A systematic review and Bayesian meta‐regression

Salvatore Mottillo MD MSc, Kristian B. Filion PhD, Lawrence Joseph PhD, Mark J. Eisenberg MD MPH

Background: Guidelines recommend routine monitoring of unfractionated heparin (UFH) with activated clotting time (ACT) during percutaneous coronary intervention (PCI). However, the optimal ACT for patients undergoing PCI is unclear.

15 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Five‐year follow‐up of polymer‐free sirolimus‐ and probucol‐eluting stents versus new generation zotarolimus‐eluting stents in patients presenting with st‐elevation myocardial infarction

Roisin Colleran MB BCH, Sebastian Kufner MD, Yukinori Harada MD, Daniele Giacoppo MD, Salvatore Cassese MD, PhD, Janika Repp MD, Jens Wiebe MD, Raphaela Lohaus MD, Annalena Lahmann MD, Simon Schneider MD, Tareq Ibrahim MD, Karl‐Ludwig Laugwitz MD, Adnan Kastrati MD, Robert A. Byrne MB, BCH, PhD

Background: Patients with ST‐segment elevation myocardial infarction (STEMI) undergoing drug‐eluting stent (DES) implantation are at increased risk of late adverse events, partly explained by an exaggerated inflammatory reaction to durable‐polymer stent coatings.

15 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Late clinical outcomes for SeQuent please paclitaxel‐coated balloons in PCI of instent restenosis and de novo lesions: A single‐center, real world registry

Leia Hee PhD, Andrew Terluk MBBS, Liza Thomas PhD, Andrew Hopkins MBBS, Craig P. Juergens DMEDSC, Sidney Lo MBBS, John K. French PhD, Christian J. Mussap PhD

Objectives: The aims of this study were to evaluate clinical outcomes following PCI using SeQuent Please paclitaxel‐coated balloons (PCB) of ISR and denovo lesions (DNL), in all‐comer patients at Liverpool Hospital, Sydney, Australia.

01 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. The Athena trials: Autologous adipose‐derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction

Timothy D. Henry MD, Carl J. Pepine MD, MACC, Charles R. Lambert MD, Jay H. Traverse MD, Richard Schatz MD, Marco Costa MD, PhD, Thomas J. Povsic MD, R. David Anderson MD, MS, James T. Willerson MD, Steven Kesten MD, Emerson C. Perin MD

Objective: To assess safety and feasibility of autologous adipose‐derived regenerative cells (ADRCs), for treatment of chronic ischemic cardiomyopathy patients.

01 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Short‐versus long‐term Dual Antiplatelet therapy after drug‐eluting stent implantation in women versus men: A sex‐specific patient‐level pooled‐analysis of six randomized trials

Fadi J. Sawaya MD Marie‐Claude Morice MD Marco Spaziano MD Roxana Mehran MD Romain Didier MD Andrew Roy MD Marco Valgimigli MD, PhD Hyo‐Soo Kim MD, PhD Kyung Woo Park MD Myeong‐Ki Hong MD, PhD Byeong‐Keuk Kim MD, PhD Yangsoo Jang MD, PhD Fausto Feres MD Alexandre Abizaid MD Ricardo A. Costa MD Antonio Colombo MD Alaide Chieffo MD Gennaro Giustino MD Gregg W. Stone MD Deepak L. Bhatt MD, MPH Tullio Palmerini MD Martine Gilard MD

Background: Whether the efficacy and safety of dual antiplatelet therapy (DAPT) are uniform between sexes is unclear. We sought to compare clinical outcomes between short‐ (≤6 months) versus long‐term (≥1 year) DAPT after drug‐eluting stent (DES) placement in women and men.

01 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial

Grant W. Reed MD, Christopher P. Cannon MD, Jill Waalen MD, MPH, Paul S. Teirstein MD, Jean‐Francois Tanguay MD, Peter B. Berger MD, Dominick J. Angiolillo MD, PhD, Matthew J. Price MD

Objective: To examine the influence of smoking on the antiplatelet effect of clopidogrel following percutaneous coronary intervention (PCI).

01 enero 2017

AMERICAN HEART JOURNAL. Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long-term anticoagulation (PRAGUE-17 study).

Pavel Osmancik MD, PhD, Petr Tousek MD, PhD, Dalibor Herman MD, PhD, Petr Neuzil MD, CS, Pavel Hala MD, Josef Stasek MD, PhD, Ludek Haman MD, PhD

Background: Atrial fibrillation (AF), with a prevalence of 1% to 2%, is the most common cardiac arrhythmia. Without antithrombotic treatment, the annual risk of a cardioembolic event is 5% to 6%. The source of a cardioembolic event is a thrombus, which is usually formed in the left atrial appendage (LAA). Prevention of cardioembolic events involves treatment with anticoagulant drugs: either vitamin K antagonists or, recently, novel oral anticoagulants (NOAC). The other (nonpharmacologic) option for the prevention of a cardioembolic event involves interventional occlusion of the LAA.

01 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. Impact of total stent length after cobalt chromium everolimus‐eluting stent implantation on 3‐year clinical outcomes

Takashi Hiromasa MD, Shoichi Kuramitsu MD, Tomohiro Shinozaki MPH, Hiroyuki Jinnouchi MD, Takashi Morinaga MD, Yohei Kobayashi MD, Takenori Domei MD, Yoshimitsu Soga MD, Shinichi Shirai MD, Kenji Ando MD

Objectives: The objective was to assess whether total stent length (TSL) after cobalt‐chromium everolimus‐eluting stent (CoCr‐EES) implantation was associated with long‐term clinical outcomes.

01 febrero 2017

CATHETERIZATION & CARDIOVASCULAR INTERVENTIONS. The influence of side branch stenosis on fractional flow reserve assessment of the main branch in a swine model

Jun‐Hyok Oh MD, Seunghwan Song MD, Changhoon Kim MPH, Jeongsu Kim MD, Jin Sup Park MD, Hye Won Lee MD, Jung Hyun Choi MD, Han Cheol Lee MD, Kwang Soo Cha MD, Taek Jong Hong MD

Objectives: The aim of this study was to explore the effect of one stenosis in a daughter artery on the fractional flow reserve (FFR) of another stenosis parallels in side branch. Background: The impact of one stenosis on the FFR of another parallel stenosis has not been evaluated. Methods: The proximal segments of the left anterior descending (LAD) and left circumflex (LCX) arteries were exposed and encircled with a Teflon pledget complex in seven swine (55–70 kg). Five degrees of stenosis (to approximate angiographic diameter stenoses of 0%, 25%, 50%, 75%, and 100%) were made by tightening the pledgets. FFR was evaluated simultaneously in the LAD and the LCX with two pressure wires in each coronary artery. A mixed‐effects linear model was used to evaluate the association between the FFR values. Results: A total of 115 paired FFR values were obtained. The FFR of the LAD and LCX were not significantly associated with each other (F = 0.237 and P = 0.627 for the LCX FFR to predict the LAD FFR; F = 0.541 and P = 0.463 for the LAD FFR to predict the LCX FFR). Conclusions: The individual FFR values of each parallel stenosis in the LAD and the LCX were not significantly influenced by each other. This relationship was independent of the mean aortic pressure and heart rate.

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.